Results 61 to 70 of about 3,959,577 (361)

Gestational weight gain and group prenatal care: A systematic review and meta-analysis [PDF]

, 2019
Background Group visits for chronic medical conditions in non-pregnant populations have demonstrated successful outcomes including greater weight loss compared to individual visits for weight management.
AA Mamun, Adam K. Lewkowitz, AG Tsai, B Hill, B Muktabhant, BE O'Donnell, C Klima, D Edelman, D Moher, DA Renjilian, DE Clancy, DR Black, E Oken, E Oken, E Ruiz-Mirazo, EB Carter, Ebony Carter, EE Tanner-Smith, G Trotman, HM Holbrook, HP Kennedy, Institute of Medicine, J Brumley, J Sheeder, JR Ickovics, LA Gilmore, LF Stead, M Kotelchuck, MA Kominiarek, MA Kominiarek, Melissa Simon, Michelle A. Kominiarek, MM Schellinger, NP Deputy, R Zielinski, RB Walton, RE Burke, S Heshka, S Phelan, S Phelan, S Rising, SE Mazzoni, SH Downs, SM Brokaw, SM Harden, SR O'Connor, Susan A. Fowler, TE Trudnak, U Magriples, V Paul-Ebhohimhen, W Wolfe, WC Knowler   +51 more
core   +2 more sources

Cohort Profile: The Nigerian HIV Geriatric Cohort Study [PDF]

BMC Public Health, 2019
Abstract Background: An estimated 280,000 adults aged 50 years and above live with HIV in Nigeria, a population set to increase with ART efficacy and expanding coverage. To learn how elderly people living with HIV (EPLHIV) in Nigeria fare, despite not being prioritized by the national treatment program, and to deepen knowledge for their ...
Patrick Dakum, Yohanna Kambai Avong, Michael Kolawole Odutola, James Okuma, Gbenga Ayodele Kayode, Iboro Ekpo Nta, Nicaise Ndembi, Charles Mensah, Hadiza Khamofu, Prosper Okonkwo, John Oko Okpanachi, Echezona Ezeanolue   +11 more
openaire   +4 more sources

Clinical applications of next‐generation sequencing‐based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression

Molecular Oncology, EarlyView.
Circulating tumor DNA (ctDNA) offers a possibility for different applications in early and late stage breast cancer management. In early breast cancer tumor informed approaches are increasingly used for detecting molecular residual disease (MRD) and early recurrence. In advanced stage, ctDNA provides a possibility for monitoring disease progression and
Eva Valentina Klocker, Samantha Hasenleithner, Rupert Bartsch, Simon P. Gampenrieder, Daniel Egle, Christian F. Singer, Gabriel Rinnerthaler, Michael Hubalek, Katja Schmitz, Zsuzsanna Bago‐Horvath, Andreas Petzer, Sonja Heibl, Ellen Heitzer, Marija Balic, Michael Gnant   +14 more
wiley   +1 more source

Screening mammography performance according to breast density: a comparison between radiologists versus standalone intelligence detection

Breast Cancer Research
Background Artificial intelligence (AI) algorithms for the independent assessment of screening mammograms have not been well established in a large screening cohort of Asian women.
Mi-ri Kwon, Yoosoo Chang, Soo-Youn Ham, Yoosun Cho, Eun Young Kim, Jeonggyu Kang, Eun Kyung Park, Ki Hwan Kim, Minjeong Kim, Tae Soo Kim, Hyeonsoo Lee, Ria Kwon, Ga-Young Lim, Hye Rin Choi, JunHyeok Choi, Shin Ho Kook, Seungho Ryu   +16 more
doaj   +1 more source

Descriptive epidemiology of muscle-strengthening activities in Japanese middle-aged and older adults: the Hisayama Study

BMJ Public Health
Introduction Data on the prevalence of muscle-strengthening activities in Asia have been limited. Using data from a community-based cross-sectional survey of a general adult population in Japan, whose age and occupational distribution were very similar ...
Jun Hata, Toshiharu Ninomiya, Takanari Kitazono, Takanori Honda, Mao Shibata, Satoko Sakata, Emi Oishi, Yoshihiko Furuta   +7 more
doaj   +1 more source

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials

Molecular Oncology, EarlyView.
In this explorative biomarker analysis, we assessed serial sampling of circulating tumor cells (CTCs) with CellSearch in two randomized trials testing immune checkpoint inhibitors (ICIs) in metastatic breast cancer. Our data demonstrate a prognostic potential of CTCs, most apparent 4 weeks into ICI therapy.
Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Elin Borgen, Cecilie Bendigtsen Schirmer, Bjørnar Gilje, Øystein Garred, Jon Lømo, Marius Stensland, Oddmund Nordgård, Ragnhild Sørum Falk, Randi R. Mathiesen, Hege G. Russnes, Jon Amund Kyte, Bjørn Naume   +13 more
wiley   +1 more source

Fast Accelerated Failure Time Modeling for Case-Cohort Data [PDF]

Statistics and Computing 2014 24:559-568, 2012
Semiparametric accelerated failure time (AFT) models directly relate the predicted failure times to covariates and are a useful alternative to models that work on the hazard function or the survival function. For case-cohort data, much less development has been done with AFT models.
arxiv   +1 more source

Systematic review of birth cohort studies in Africa [PDF]

, 2011
In sub-Saharan Africa, unacceptably high rates of mortality amongst women and children continue to persist. The emergence of research employing new genomic technologies is advancing knowledge on cause of disease. This review aims to identify birth cohort
Campbell, Alasdair, Rudan, Igor
core   +1 more source

Cohort Profile: the Jerusalem longitudinal cohort study [PDF]

International Journal of Epidemiology, 2008
Whilst it has been suggested that about 25% of the variability in human longevity is attributed to genetic influences, the remaining 75% is consequent upon a complex interplay of biological, environmental, social and culturally determined factors. In rising to the challenge of understanding the complexities of human ageing, a valuable tool to emerge in
Eliana Ein-Mor, Jochanan Stessman, Michael Bursztyn, Daniel Azoulay, Jeremy M. Jacobs, Aaron Cohen   +5 more
openaire   +3 more sources

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

Molecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi, Janelle‐Cheri Millen, Romela Irene Ramos, Jennifer A. Linehan, Timothy G. Wilson, Dave S. B. Hoon, Matias A. Bustos   +6 more
wiley   +1 more source